Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Because UC patients are at increased risk for developing colorectal cancer (CRC), we investigated if there was an association between SNPs in the promoter of the TNF-alpha gene and UC-CRC.
|
18289203 |
2008 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The -308 G/A SNP in the TNF-alpha promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region.
|
18698679 |
2008 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis.
|
19286392 |
2009 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Both TNF-alpha mRNA (P = 0.03) and IL-6 mRNA (P = 0.04) were higher in UC compared with ICC.
|
18942752 |
2009 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our analyses showed positive associations between proinflammatory polymorphisms at IL1RN and TNFA-307 loci and UC, as well as polymorphisms in the NOD2 gene and CD.
|
18942754 |
2009 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves.
|
19617644 |
2009 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.
|
20452301 |
2010 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
The highest levels of TNF-α were detected in the UC group.
|
21877213 |
2011 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Ten candidate SNPs, multidrug resistance 1 (MDR1) 3435 (C>T), regulated upon activation, normal T-cell expressed and secreted (RANTES)-28 (C>G), heat-shock protein (HSP)70-2 1267 (B>A), NADPH oxidase p22PHOX 242 (C>T), Toll-like receptor (TLR)2-196 to -174 (ins >del), CD14-159 (C>T), Mannan-binding lectin (MBL)2 codon 54 (G>A), tumor necrosis factor-α(TNF-α) -857 (C>T), interleukin-1β(IL-1β)-511 (C>T), and IL-1β -31 (T>C) were genotyped in 58 UC patients without neoplastic lesions, in relation to CIHM in the rectal mucosa of three candidate CpG (p14, p16 and E-cadherin: CDH1) loci, assessed by methylation-specific-polymerase chain reaction (MSP).
|
21498716 |
2011 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Pooled odd ratios (ORs) and 95% confidence intervals (95% CIs) were calculated on the basis of data from 14, 18, and 7 studies from a total of 27 studies for the associations between the polymorphism of TNF-α-308 G>A and ulcerative colitis, Crohn's disease (CD) and CRC.
|
21248737 |
2011 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Tumor necrosis factor (TNF) superfamily gene-15 (SF15) polymorphisms were associated with CD (OR 2.68; 95% CI 1.86-3.86), while TNF-308 polymorphisms (OR 1.82; 95% CI 1.15-2.9), cytotoxic T lymphocyte antigen (CTLA)-4 (OR 2.75; 95% CI 1.22-6.22) and MICA allele (OR 2.41; 95% CI 1.89-3.07) were associated with ulcerative colitis in Asians.
|
21887729 |
2012 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine.
|
22119283 |
2012 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Reverse causal reasoning on mRNA expression data from anti-TNFα-naïve UC and normal samples provided a mechanistic disease model of the biology of gene expression observed in UC. mRNA expression data from the ACT 1 study enabled construction of a mechanistic model describing the biology of nonresponders to infliximab, including evidence for increased intestinal permeability compared with normal and responder samples.
|
22223479 |
2012 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
BEFREE |
However, the correlation was observed between serum concentrations of leptin in patients with exacerbation of UC and serum concentrations of proinflammatory cytokines IL-1β and TNF-α.
|
23211301 |
2012 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.
|
22960943 |
2013 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Inflamed mucosa with spontaneous hemorrhage may suggest increased expression of TNF-α mRNA levels in colonic mucosa of UC patients, which could predict a lower response to infliximab treatment and more aggressive induction regime or change to other therapy should be taken into account.
|
23377880 |
2013 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
The expression of AQP8 mRNA and protein were decreased in UC tissue and tumor necrosis factor (TNF)-α treated HT29 cells compared with controls (P < 0.05).
|
23595390 |
2013 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Taken together, this study determines the levels of miR-19a and TNF-α in both DSS-induced experimental murine colitis and human UC and further demonstrates that miR-19a might directly regulate TNF-α.
|
23795660 |
2013 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
BEFREE |
High levels of KV1.3 in CD4 and CD8 positive T-cells infiltrates are associated with production of pro-inflammatory IL-17A and TNF-α in active UC.
|
24793818 |
2014 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Moreover, we found individual disease risk loci: TNFSF15 and TNFα to CD and HLA-B*5201, and NFKBIL1 to UC.
|
23942620 |
2014 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
The expression of CDX2 was decreased in the epithelium of patients with ulcerative colitis (UC), and the expression was inversely correlated with the level of TNF-α.
|
24814920 |
2014 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Protective association of tumor necrosis factor superfamily 15 (TNFSF15) polymorphic haplotype with Ulcerative Colitis and Crohn's disease in an Indian population.
|
25501099 |
2014 |
Ulcerative Colitis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The polymorphisms TLR2 (rs1816702), NFKB1 (rs28362491), TNFRSF1A (rs4149570), IL6R (rs4537545), IL23R (rs11209026) and PTPN22 (rs2476601) were associated with risk of CD and the polymorphisms TLR2 (rs1816702), TLR4 (rs1554973 and rs12377632), TLR9 (rs352139), LY96 (rs11465996), NFKBIA (rs696), TNFA (rs1800629), TNFRSF1A (rs4149570), IL10 (rs3024505), IL23R (rs11209026), PTPN22 (rs2476601) and PPARG (rs1801282) were associated with risk of UC.
|
24971461 |
2014 |
Ulcerative Colitis
|
0.600 |
Biomarker
|
disease |
RGD |
"[Exploration of the theory of ""Fei and Dachang being interior-exteriorly related"" from observing changes of inflammatory cytokines and oxygen free radicals in the lung tissue of ulcerative colitis rats]."
|
24812904 |
2014 |
Ulcerative Colitis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Elevation of PRKCDBP, a novel transcriptional target of TNF-α, and its downregulation by infliximab in patients with ulcerative colitis.
|
25052149 |
2014 |